Page 22 - IMO-2-2
P. 22
Innovative Medicines & Omics Pharmacotherapy of obesity
doi: 10.1016/B978-0-12-817921-5.00001-1 in obesity and its determinants in Spain: What happens
beyond the obesity threshold? Int J Health Econ Manag.
20. Chooi YC, Ding C, Magkos F. The epidemiology of obesity.
Metabolism. 2019;92:6-10. 2024;24(1):135-153.
doi: 10.1016/J.METABOL.2018.09.005 doi: 10.1007/s10754-023-09360-1
21. Son JW, Kim S. Comprehensive review of current and upcoming 33. Kenney EL, Poole MK, McCulloch SM, et al. School-based
anti-obesity drugs. Diabetes Metab J. 2020;44:802-818. nutrition education programs alone are not cost effective for
preventing childhood obesity: A microsimulation study. Am
doi: 10.4093/dmj.2020.0258 J Clin Nutr. 2024; 121:167-173.
22. Chacin M, Carrillo-Sierra S, Duran P, et al. Epidemiological doi: 10.1016/J.AJCNUT.2024.11.006
behavior of childhood obesity: A continental point of view.
F1000Res. 2024;13:177. 34. Burki T. European Commission classifies obesity as a
chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418.
doi: 10.12688/f1000research.139123.1
doi: 10.1016/S2213-8587(21)00145-5
23. Lin X, Li H. Obesity: Epidemiology, pathophysiology, and
therapeutics. Front Endocrinol (Lausanne). 2021;12:706978. 35. Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon
Rectal Surg. 2011;24(4):205-210.
doi: 10.3389/fendo.2021.706978
doi: 10.1055/s-0031-1295684
24. Tsoi MF, Li HL, Feng Q, Cheung CL, Cheung TT, Cheung
BMY. Prevalence of childhood obesity in the United States in 36. Endalifer ML, Diress G. Epidemiology, predisposing
1999-2018: A 20-year analysis. Obes Facts. 2022;15(4):560-569. factors, biomarkers, and prevention mechanism of obesity:
A systematic review. J Obes. 2020;2020:6134362.
doi: 10.1159/000524261
doi: 10.1155/2020/6134362
25. Janssen F, Bardoutsos A, Vidra N. Obesity prevalence in the
long-term future in 18 European countries and in the USA. 37. Cawley J, Biener A, Meyerhoefer C, et al. Direct medical
Obes Facts. 2020;13(5):514-527. costs of obesity in the United States and the most populous
states. J Manag Care Spec Pharm. 2021;27(3):354-366.
doi: 10.1159/000511023
doi: 10.18553/jmcp.2021.20410
26. Lingvay I, Cohen RV, Le Roux CW, Sumithran P. Obesity in
adults. Lancet. 2024;404(10456):972-987. 38. Von Lengerke T, Krauth C. Economic costs of adult obesity:
A review of recent European studies with a focus on
doi: 10.1016/S0140-6736(24)01210-8
subgroup-specific costs. Maturitas. 2011;69(3):220-229.
27. Purdy JC, Shatzel JJ. The hematologic consequences of
obesity. Eur J Haematol. 2021;106(3):306-319. doi: 10.1016/J.MATURITAS.2011.04.005
doi: 10.1111/ejh.13560 39. D’Errico M, Pavlova M, Spandonaro F. The economic burden
of obesity in Italy: A cost-of-illness study. Eur J Health Econ.
28. Marcus C, Danielsson P, Hagman E. Pediatric obesity-long- 2022;23(2):177-192.
term consequences and effect of weight loss. J Intern Med.
2022;292(6):870-891. doi: 10.1007/s10198-021-01358-1
doi: 10.1111/joim.13547 40. Colditz GA. Economic costs of obesity. Am J Clin Nutr.
1992;55(2):503S-507S.
29. Mertens IL, Van Gaal LF. Overweight, obesity, and blood
pressure: The effects of modest weight reduction. Obes Res. doi: 10.1093/AJCN/55.2.503S
2000;8(3):270-278. 41. Van Der Valk ES, Van Den Akker ELT, Savas M, et al.
doi: 10.1038/oby.2000.32 A comprehensive diagnostic approach to detect underlying
causes of obesity in adults. Obes Rev. 2019;20:795-804.
30. Halal CSE, Matijasevich A, Howe LD, Santos IS, Barros
FC, Nunes ML. Short sleep duration in the first years of life doi: 10.1111/obr.12836
and obesity/overweight at age 4 years: A birth cohort study. 42. El Khoury D, Cuda C, Luhovyy BL, Anderson GH. Beta
J Pediatr. 2016;168:99-103.e3. glucan: Health benefits in obesity and metabolic syndrome.
doi: 10.1016/j.jpeds.2015.09.074 J Nutr Metab. 2012;2012:28.
31. Shinde S, Tran AT, Jerry M, Lee CJ, Lilly E. Work loss among doi: 10.1155/2012/851362
privately insured employees with overweight and obesity in 43. Zeng Q, Li N, Pan XF, Chen L, Pan A. Clinical management
the United States. Obes Sci Pract. 2024;10:e775. and treatment of obesity in China. Lancet Diabetes
doi: 10.1002/osp4.775 Endocrinol. 2021;9(6):393-405.
32. Raftopoulou A, Gil Trasfi J. Income-related inequality doi: 10.1016/S2213-8587(21)00047-4
Volume 2 Issue 2 (2025) 16 doi: 10.36922/imo.8316

